Cargando…
Teprotumumab and the Evolving Therapeutic Landscape in Thyroid Eye Disease
CONTEXT: Thyroid eye disease (TED) is a sight-threatening and debilitating autoimmune condition, with limited therapies available, that often poses diagnostic and therapeutic challenges. In recent years, the treatment landscape has shifted to early intervention with targeted therapy. METHODS: A PubM...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359446/ https://www.ncbi.nlm.nih.gov/pubmed/36346685 http://dx.doi.org/10.1210/clinem/dgac168 |